Savvidou Α. (2026) “Real-World Data on the Use of Cyclin-Dependent Kinase 4/6 Inhibitors in Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced/Metastatic Breast Cancer”, World Journal of Oncology, 17(3), pp. 380–393. doi:10.14740/wjon2750.